Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
In Vivo Activity of Aryl Ozonides against Schistosoma Species
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1027610
Author(s) Keiser, J.; Ingram, K.; Vargas, M.; Chollet, J.; Wang, X.; Dong, Y.; Vennerstrom, J. L.
Author(s) at UniBasel Keiser, Jennifer
Year 2011
Title In Vivo Activity of Aryl Ozonides against Schistosoma Species
Journal Antimicrobial agents and chemotherapy
Volume 56
Number 2
Pages / Article-Number 1090-2
Mesh terms Animals; Anthelmintics, therapeutic use; Female; Heterocyclic Compounds, therapeutic use; Mice; Schistosoma haematobium, drug effects; Schistosoma mansoni, drug effects; Schistosomiasis haematobia, parasitology; Schistosomiasis mansoni, parasitology; Treatment Outcome
Abstract We evaluated the in vivo antischistosomal activities of 11 structurally diverse synthetic peroxides. Of all compounds tested, ozonide (1,2,4-trioxolane) OZ418 had the highest activity against adult Schistosoma mansoni with total and female worm burden reductions of 80 and 90% (p < 0.05). Furthermore, treatment of S. haematobium infected mice with OZ418 reduced total worm burden by 86%. In conclusion, OZ418 is a promising antischistosomal lead compound
Publisher American Society for Microbiology
ISSN/ISBN 0066-4804
URL http://www.ncbi.nlm.nih.gov/pubmed/22106214
edoc-URL http://edoc.unibas.ch/47147/
Full Text on edoc No
Digital Object Identifier DOI 10.1128/AAC.05371-11
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/22106214
ISI-Number WOS:000299658900067
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.356 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
02/05/2024